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Abstract
Background: Trimester-specific reference ranges for T3, T4, and TSH need to be established in different communities.
Neither Sudan nor other African countries have established trimester-specific reference ranges for TSH, free T3 (FT3),
and free T4 (FT4) in healthy pregnant women. This study aimed to establish trimester-specific reference ranges for TSH,
FT3, and FT4 in healthy pregnant Sudanese women.
Results: We performed a longitudinal study, which included 63 women with singleton pregnancies who were followed
since early pregnancy until the third trimester. The study was performed in Saad Abu-Alela Hospital, Khartoum, Sudan,
during January to October 2014. An equal number of age- and parity-matched non-pregnant women were enrolled as a
control group. Basic clinical and obstetrics data were gathered using questionnaires. TSH, FT3, and FT4 levels
were measured. Median (5th–95th centile) values of TSH, FT3, and FT4 were 1.164 IU/ml (0.079–2.177 IU/ml),
4.639 nmol/l (3.843–6.562 nmol/l), and 16.86 pmol/l (13.02–31.48 pmol/l) in the first trimester. Median values
of TSH, FT3, and FT4 were 1.364 IU/ml (0.540–2.521 IU/ml), 4.347 nmol/l (3.425–5.447 nmol/l), and 13.51 pmol/l (11.04–31.
07 pmol/l) in the second trimester. These values were 1.445 IU/ml (0.588–2.460 IU/ml), 4.132 nmol/l (3.176–5.164 nmol/l),
and 12.87 pmol/l (9.807–23.78 pmol/l) in the third trimester, respectively. TSH levels increased throughout the trimesters.
FT3 and FT4 levels were significantly higher in the first trimester compared with the second and third trimesters. TSH,
FT3, and FT4 levels were significantly lower in pregnant women compared with non-pregnant women (P < 0.001).
Conclusions: The present study is the first to establish trimester-specific reference ranges of TSH, FT3, and FT4 in
Sudanese women with normal pregnancies. Our results suggest that pregnancy is likely to suppress TSH, T3, and T4
levels in healthy women.
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Background
Pregnancy may be associated with alterations in iodine
homeostasis and other physiological changes that ultim-
ately result in alteration of thyroid function [1, 2]. Several
community-based cohort studies were conducted to estab-
lish trimester-specific reference ranges (TSRRs) for T3, T4,
and TSH in different communities [3–10]. Studies have
shown considerable variations in the thyroid hormone pro-
file among populations of different origin, probably owing
to modulatory effects of ethnicity [11], parity [12], body
mass index (BMI) [13], iodine insufficiency [1, 2], and cer-
tain pregnancy-induced disorders [14, 15] of thyroid func-
tion. Establishing TSRRs of TSH, free T3 (FT3), and free
T4 (FT4) are therefore crucial for meticulous evaluation of
thyroid function during pregnancy. Maternal thyroid func-
tion should be maintained within normal limits, especially
during the first trimester. In the first trimester, the embryo
is completely dependent on the mother’s thyroid hormones
for development of the brain [16], as well as other tissues
[17, 18].
Many studies have been conducted worldwide to estab-
lish TSRRs in different countries [3–10]. However, similar
studies in Sudan [19] and other African countries [20] are
scarce. A previous study that assessed iodine status in 21
pregnant Sudanese women reported trimester-specific
interquartile ranges of TSH, T3, and T4 [19]. However,
the sample size was inadequate for establishing TSRRs for
thyroid hormones in Sudan. A study in Nigeria evaluated
the effect of iodine deficiency on thyroid function during
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pregnancy, and reported TSRRs of TSH, T3, and T4 based
on a small sample size of 27 [20].
To the best of our knowledge, no other studies have
been conducted to establish TSRRs for healthy pregnant
women either in Sudan or in other African countries.
The current study was conducted to establish TSRRs for
healthy pregnant Sudanese women. Our findings are ex-
pected to assist in accurate interpretation of laboratory
results, proper diagnosis, and management of thyroid
dysfunction among Sudanese women during pregnancy.
Methods
We conducted a longitudinal study in Saad Abu-Alela Hos-
pital (Khartoum, Sudan) during January to October 2014.
Women with a singleton pregnancy were enrolled early in
pregnancy (once their pregnancy was confirmed) and
followed until the third trimester. After patients signed an
informed consent, the sociodemographic, medical, and ob-
stetrics history (age, parity, gravidity, and gestational age)
was recorded from each woman using a questionnaire.
Pregnancy and its duration were confirmed by ultrasound,
which was conducted by the practicing obstetricians (MAA
and IA) as part of antenatal investigations. During the
current longitudinal study, an equal number of non-
pregnant women (pregnancy was excluded by ultrasound)
matched for age and parity were included as controls. Preg-
nant and non-pregnant women who had a previous history
of thyroid disease, hypertension, renal disease, diabetes,
liver disease, and those on medication that might affect
thyroid function were excluded from the study.
Blood pressure was measured using a sphygmoman-
ometer for the case and control groups. During the first
visit (in early pregnancy), maternal weight and height
were measured. BMI was calculated and expressed as
weight (kg)/height (m2). BMI during the first trimester is
likely comparable with pre-conception BMI, which was
difficult to get in our study population. Hemoglobin was
measured for each patient at every visit.
A volume of 5 ml of venous blood was taken from each
patient, allowed to clot, centrifuged, and stored at −20 °C
until assay of thyroid hormones (TSH, FT3, FT4) using
the immunoassay analyzer AIA 360 TOSOH (Japan),
guided by the manufacturer’s instructions as described
previously [15]. Noteworthy, the aim of present study was
to get TSRRs of TSH, FT3 and FT4 regardless of parity or
residence. Thus data were not dissected. The reference in-
tervals for TSH, FT3, and FT4 for our laboratory were as
follows: TSH, 0.38–4.3 IU/ml; FT3, 3.23–5.13 pmol/l; and
FT4, 10.55–20.9 pmol/l.
A total required sample size of 63 women was calcu-
lated using a formula for a longitudinal study and the dif-
ference in the mean of the proposed variables (TSH, FT3,
and FT4 as in our previous study [15]) that would provide
80 % power to detect a 5 % difference at α = 0.05. We
assumed that 10 % of women will be lost during follow-up
or will not respond.
Statistical analysis
Data were entered into a computer using SPSS for
Windows (version 16.0). The 5th–95th centile and me-
dian were calculated for levels of TSH, FT3, and FT4.
Levels of TSH, FT3, and FT4 were not normally distrib-
uted (assessed using the Shapiro–Wilk normality test),
and differences were assessed using the Kruskal–Wallis
H test (Mann–Whitney U test between two groups). A
P value < 0.05 was considered significant.
Results
Among 75 pregnant women who were initially enrolled,
63 (84.0 %) completed the follow-up until the third tri-
mester. The rest (16.0 %) of the patients were lost during
follow-up because of a change in address.
Approximately half of these women were primiparous
(n = 34.0, 54.0 %), the majority were housewives (n = 45,
71.4 %), and few of them had a rural residence (n = 9,
14.3 %). Hemoglobin level and the other basic character-
istics of the women are shown in Table 1.
TSH, FT3, and FT4 levels were significantly lower in
pregnant women compared with non-pregnant women
(Table 2). Median (5th–95th centile) values of TSH,
FT3, and FT4 in pregnant women were 1.164 IU/ml
(0.079–2.177 IU/ml), 4.639 nmol/l (3.843–6.562 nmol/l),
and 16.86 pmol/l (13.02–31.48 pmol/l) in the first tri-
mester. Median values of TSH, FT3, and FT4 were
1.364 IU/ml (0.540–2.521 IU/ml), 4.347 nmol/l (3.425–
5.447 nmol/l), and 13.51 pmol/l (11.04–31.07 pmol/l) in
the second trimester. These values were 1.445 IU/ml
(0.588–2.460 IU/ml), 4.132 nmol/l (3.176–5.164 nmol/l),
and 12.87 pmol/l (9.807–23.78 pmol/l) in the third
trimester, respectively.
Table 1 Mean (SD) of the characteristics of the enrolled
pregnant women (n = 63)
Variable Mean (SD)
Age, years 27.0 (4.9)
Parity 0.8 (1.1)
Gravidity 2.5 (4.0)
Body mass index 27.9 (5.4)
Gestational age, weeks
First trimester 10.8 (2.9)
Second trimester 21.5 (4.0)
Third trimester 31.2 (3.4)
Hemoglobin, gm/dl
First trimester 10.6 (1.0)
Second trimester 10.6 (0.6)
Third trimester 10.9 (1.1)
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TSH levels increased over the trimesters, with signifi-
cantly higher TSH levels in the second and third trimes-
ters compared with the first trimester (Table 2, Fig. 1).
FT3 levels were significantly higher in the first trimes-
ter compared with the second and third trimesters.
However, no significant difference was observed in FT3
levels between the second and third trimesters (Table 2
and Fig. 2).
FT4 levels showed significant variation between the
first and second trimesters, as well as between the first
and third trimesters. FT4 levels were lowest during the
third trimester. No significant difference in FT4 levels
was observed between the second and third trimesters
(Table 2 and Fig. 3).
Discussion
The present study is the first to establish TSRRs of TSH,
FT3, and FT4 in healthy Sudanese pregnant women. A
previous study by Eltom et al. assessed iodine status dur-
ing pregnancy in Sudan [19]. They observed comparable
trimester-specific TSH levels, but lower T3 and T4 inter-
quartile ranges, compared with our results (Table 3).
Table 2 Median (5th–95th centile) values of thyroid hormones in pregnant and non-pregnant Sudanese women
Variable Non- pregnant Trimester-I Trimester-II Trimester-III P
Mean = 10.8 weeks Mean =21.5 weeks Mean =31.2 weeks
TSH, IU/ml 2.080 (0.776–4.550) 1.164 (0.079–2.177) 1.364 (0.540–2.521) 1.445 (0.588–2.460) Non- Pregnant vs. Pregnant P < 0.001
Trimester-I vs. Trimester-II P = 0.042
Trimester-I vs. Trimester-III P = 0.007
Trimester-II vs. Trimester-III P = 0.482
Free T3, pmol/l 5.176 (4.156–6.095) 4.639 (3.843–6.562) 4.347 (3.425–5.447) 4.132 (3.176–5.164) Non- Pregnant vs. Pregnant P < 0.001
Trimester-I vs. Trimester-II P < 0.001
Trimester-I vs. Trimester-III P < 0.001
Trimester-I vs. Trimester-III P = 0.064
Free T4, pmol/l 16.34 (12.6–19.9) 16.86 (13.02–31.48) 13.51 (11.04–31.07) 12.87 (9.807–23.78) Non- Pregnant vs. Pregnant P < 0.001
Trimester-I vs. Trimester-II P = 0.008
Trimester-I vs. Trimester-III P < 0.001
Trimester-I vs. Trimester-III P =0.078
Fig. 1 Distribution of TSH levels among controls and different trimesters in pregnant women
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Fig. 2 Distribution of T3 levels among controls and different trimesters in pregnant women
Fig. 3 Distribution of T4 among controls and different trimesters in pregnant women
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They evaluated 21 pregnant Sudanese women, which
was an inadequate sample size to establish TSRRs for
thyroid hormones in Sudan. Similar to the present fin-
dings, they found that TSRRs of T3 and T4 were lowest
in the third trimester. In contrast, maximum TSH levels
were reported in the second trimester [19]. To the best
of our knowledge, there have been no studies on TSRRs
for healthy pregnant women in any of the African coun-
tries. A previous Nigerian study examined the effect of
iodine deficiency on thyroid function during pregnancy
[20]. TSRRs of TSH, T3, and T4 were calculated after
evaluating 27 African women with a normal pregnancy
[20]. As shown in Table 4, TSRRs of TSH in all trimes-
ters were higher in the Nigerian study compared with
the current study on pregnant Sudanese women. In con-
trast, thyroid hormone levels were higher in pregnant
Sudanese women, especially T4, compared with Nigerian
women. TSRRs of TSH, FT3, and FT4 levels in pregnant
Sudanese women showed a unique trend compared with
previous studies in other countries. TSRRs of TSH in
Sudanese are comparable with some Western countries
(Table 4) [3, 4], but relatively lower compared with some
Arab [5], Persian [6], and Eastern countries [7, 8]. TSRRs
of T4, and to some extent T3, are higher in Sudanese
women compared with other countries (Table 4) [3–10].
TSH and thyroid hormones show day/night [21] and
seasonal variation [22, 23]. These hormones are also af-
fected by iodine intake [23] and excretion [24], ambient
temperature [25], luminosity and other ecological/gen-
etic factors [26–28]. These biological and environmental
factors are unlikely to be comparable worldwide, which
could explain the variation in TSRRs of TSH, T3, and
T4 in different countries. The variation in TSRRs can
also be explained by variable accuracy of the techniques
used for thyroid hormonal assays [29, 30] and a lack of
standardized preanalytical conditions (i.e., procedure and
timing of blood sampling) [31, 32]. Ideally, blood sam-
ples for thyroid hormone assays should be collected
without the aid of a tourniquet from a rested individual
in the fasting state [30]. Blood samples should be taken
at the same hour of the day to avoid the effect of circa-
dian rhythm on TSH, T3, and T4 [21].
Table 4 shows that levels of TSH, FT3, and FT4 were
lower in pregnant women compared with the control
group. In our study, a maximum decrease in thyroid
function was achieved in the second trimester, with no
significant change in thyroid hormone levels up to the
end of pregnancy. In a Turkish study, TSH levels of
pregnant women were significantly lower than those of
non-pregnant controls in the first trimester [9] (Table 4).
However, TSH levels were comparable with non-pregnant
levels in the second trimester, and higher than non-
pregnant levels in the third trimester. This Turkish study
also showed that FT3 and FT4 levels were comparable in
the three trimesters [9]. Additionally, T3 levels were
higher throughout pregnancy, but T4 levels were lower in
the second and third trimesters compared with non-
pregnant controls. Chinese pregnant women showed a
similar pattern of trimester-specific TSH changes that
were observed in Turkish women, but FT4 and FT3 levels
decreased as pregnancy progressed [8] (Table 4). A previ-
ous study that examined pregnant women with different
ethnicities in the United Arab Emirates showed that lower
TSH levels in the first trimester increased to non-
pregnant control levels in the third trimester [5].
Additionally, FT4 showed a steady decrease throughout
pregnancy (Table 4). The findings of the United Arab
Emirates study were reproduced in another two studies
that intended to establish TSRRs of thyroid hormones in
Korean [33] and Irish [34] women.
The physiological basis of the pattern of changes in TSH,
FT3, and FT4 during pregnancy has been extensively stud-
ied towards the end of the last century [35, 36]. Most pre-
vious studies attributed variations in the levels of thyroid
hormones throughout pregnancy to non-pituitary hormo-
nal control mechanisms [37]. Researchers have hypothe-
sized that human chorionic gonadotropin (hCG) hormone
can stimulate TSH receptors, with subsequent release of
T3 and T4 from follicular thyroid cells during the first tri-
mester [38]. Thyroid hormones negatively feedback on the
pituitary gland and thus decrease TSH levels [39]. High es-
trogen levels induced by hCG may markedly decrease free
T3 and T4 levels by increasing their transport proteins. As
a result, TSH is expected to increase, contradicting the thy-
rotropic action of hCG [40]. These contradictory actions of
hCG on TSH levels suggest that the hypothesis that attri-
butes the second and third trimester TSH surge to hCG
withdrawal is questionable [41, 42]. The current study and
at least two other studies showed a significant decrease in
TSH levels in the second trimester, but were not able to
explain this finding [43, 44]. Notably, a concurrent de-
crease in TSH levels with FT3 and FT4 levels excludes iod-
ine insufficiency as a probable cause of decreased thyroid
hormones in the Sudanese pregnant women in our study.
This is because, in such conditions, TSH is expected to in-
crease as a compensatory mechanism for decreased T3
Table 3 Comparison of interquartile ranges of thyroid
hormones between our study and a previous Sudanese report
Trimester I Trimester II Trimester III
Present study TSH, IU/ml 0.6–1.6 0.9–1.7 1.0–1.8
T3, nmol/L 4.4–5.3 3.9–4.7 3.7–4.5
T4, pmol/L 15.1–21.4 12.3–17.8 11.5–16.4
Eltom et al. [19]. TSH, IU/ml 0.5–1.5 0.7–1.8 0.6–1.6
T3, nmol/L 2.1–3.2 2.2–3.5 2.2–2.9
T4, pmol/L 9.6–13.4 8.6–10.8 9.4–12.6
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and T4 levels. To the best of our knowledge, a further de-
crease in TSH levels in the second trimester is unclear and
may preclude hCG withdrawal as a probable explanation
for low hCG levels in the first trimester.
Notably, TSRRs that were established in the present
study were derived by following up Sudanese women
with a normal pregnancy throughout the three trimes-
ters. Our study design avoids between-individual vari-
ation as a possible confounder for the apparent
differences in TSRRs of TSH, T3, and T4 demonstrated
in this study. However, within-individual variation (e.g.,
seasonal variation) [22, 23] of TSH and thyroid hor-
mones remains a possible bias for the current findings.
Another limitation of this study is that we did not evalu-
ate iodine homeostasis in pregnant women. However, a
simultaneous decrease in TSH and thyroid hormones
exclude iodine insufficiency as a probable explanation of
hypothyroid function in pregnant women in our study.
This is because in such conditions, decreased T3 and T4
levels are expected to feedback positively on TSH and
increase its level. Evaluation of urine iodine concentra-
tions in future studies may provide further verification
of this hypothesis.
Conclusions
The present study is the first to establish TSRRs of TSH,
FT3, and FT4 in Sudan. Pregnancy is likely to suppress
TSH, T3, and T4 levels in Sudanese women. TSRRs of
TSH in Sudan are comparable with some Western coun-
tries, but are relatively lower compared with some Arab,
Persian, and Eastern countries. However, TSRRs of thy-
roid hormones are higher in Sudan compared with other
Table 4 Comparison of thyroid hormones between our study from Sudan and previous reports from other countries
Percentile used TFT Non-pregnant Trimester I Trimester II Trimester III
Sudan 5–95 TSH, IU/ml 0.78–4.55 0.08–2.18 0.54–2.52 0.59–2.46
T3, nmol/L 4.16–6.10 3.84–6.56 3.43–5.45 3.18–5.16
T4, pmol/L 12.6–20.0 13.00–31.53 11.07–31.2 9.78–23.81
Nigeria [20] 5–95 TSH, IU/ml – 0.5–5.0 0.5–5.0 0.5–5.0
T3, nmol/L – 1.7–3.5 1.86–3.54 1.9–3.94
T4, pmol/L – 6.1–19.7 8.5–23.3 8.9–23.3
UAE [5] 2.5–97.5 TSH, IU/ml 0.21–6.9 0.17–5.9 0.04–9.3 0.3–4.32
T3, nmol/L – – – –
T4, pmol/L 8–18 8.4–19.3 8.9–24.6 9.8–18.6
Iran [6] 5–95 TSH, IU/ml – 0.2–3.9 0.5–4.1 0.6–4.1
T3, nmol/L – – – –
T4, pmol/L – 8.5–19 9.7–21 8.7–20.4.
Turkey [9] 2.5–97.5 TSH, IU/ml 0.47–4.70 0.49–2.33 0.51–3.44 0.58–4.31
T3, nmol/L 2.96–5.48 3.80–5.81 3.69–5.90 3.67–5.81
T4, pmol/L 10.68–18.23 10.30–18.11 10.30–18.15 10.30–17.89
Switzerland [3] 2.5–97.5 TSH, IU/ml 0.35–4.94 0.06–2.83 0.20–2.79 0.31–2.90
T3, nmol/L – 3.52–6.22 3.41–5.78 3.33–5.59
T4, pmol/L 9–19.1 10.5–18.3 9.5–15.7 8.6–13.6
Spain [10] 2.5–97.5 TSH, IU/ml – 0.10–2.65 0.12–2.64 0.23–3.56
T3, nmol/L – 3.44–6.80 3.79–6.42 3.46–6.39
T4, pmol/L – 10.61–17.76 9.1–14.67 8.49–15.6
India [7] 5–95 TSH, IU/ml – 0.6–5.0 0.43–5.78 0.74–5.7
T3, nmol/L – 1.92–5.86 3.2–5.7 3.3–5.18
T4, pmol/L – 12.0–19.45 9.48–19.58 11.3–17.71
China [8] 2.5–97.5 TSH, IU/ml 0.54–4.20 0.16–3.78 0.34–3.51 0.34–4.32
T3, nmol/L – 2.9–5.0 2.9–4.6 2.9–4.5
T4, pmol/L 9.2–16.9 10.9–17.7 9.3–15.2 7.9–14.1
USA [4] 2.5–97.5 TSH, IU/ml – 0.24–2.99 0.46–2.95 0.43–2.78
T3, nmol/L – – – –
T4, pmol/L – – – –
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countries. Further research that also considers iodine
homeostasis in pregnant women may provide further
support for the conclusions of the present study.
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